Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia.
Angela C RobertsAlfred W RademakerElizabeth Ann SalleyAimee MooneyDarby MorhardtMelanie Fried-OkenSandra WeintraubMarsel MesulamEmily RogalskiPublished in: Trials (2022)
ClinicalTrials.gov NCT03371706 . Registered prospectively on December 13, 2017.